Automate Your Multiple Myeloma MRD Analysis

Replace manual gating with transparent, deterministic AI that is validated for multiple myeloma and compliant with IVDD standards.

What’s included in your offer?

Our partners

Reserve your November beta access today

Receive a personalized Asudes walkthrough for MM MRD analysis and join our limited November beta program for multiple myeloma (MRD).

Our early-access participants receive personalized onboarding and priority access to upcoming clinical features.

How does it work?

👁 Analyze

Upload your data

Seamlessly upload your .FCS files for AI-driven analysis in minutes

AI-powered analysis

Let Asudes transform raw data into actionable insights with precision

❓ Customize

Build your models

Create personalized workflows that suit your unique research needs

Set advanced parameters

Adjust scaling, transformation, and gating with just a few clicks

<p style="font-weight: bold;">View Our Product Paper</p>

See the difference: Eclipse vs. Manual Analysis

Traditional analysis using gating is manual, time-consuming, and prone to variability. Eclipse automates analysis, filters the noise, and delivers faster, clearer insights. That is why you can focus on decisions, not data processing.

Traditional Analysis

Eclipse Outcomes

Eclipse automates cell classification in minutes and eliminates manual steps, reducing errors. It is more precise, consistent, and scalable

What experts think of our platform

“The AI algorithm, Asudes, enables the intuitive graphical visualization of 24/7 complex multi-color flow analyses of immune cells, which allows for the first-time interpretation of the health state of patients with hematological malignancies by generic care professionals without the intervention of a flow-trained immunologist.”

Prof. Leo Koenderman

Head of department at the UMCU

Still unsure? Book a free meeting with our specialist.